Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Foluso, Ademuyiwa"'
Autor:
Jairam Krishnamurthy, Jingqin Luo, Rama Suresh, Foluso Ademuyiwa, Caron Rigden, Timothy Rearden, Katherine Clifton, Katherine Weilbaecher, Ashley Frith, Anna Roshal, Pavan K. Tandra, Mathew Cherian, Tracy Summa, Brittney Haas, Shana Thomas, Leonel Hernandez-Aya, Mattias Bergqvist, Lindsey Peterson, Cynthia X. Ma
Publikováno v:
npj Breast Cancer, Vol 8, Iss 1, Pp 1-7 (2022)
Abstract Palbociclib 3-weeks-on/1-week-off, combined with hormonal therapy, is approved for hormone receptor positive (HR+)/HER2-negative (HER2−) advanced/metastatic breast cancer (MBC). Neutropenia is the most frequent adverse event (AE). We aim t
Externí odkaz:
https://doaj.org/article/66f1f8841c624feda0766f004e302bc2
Publikováno v:
Breast Cancer Research, Vol 21, Iss 1, Pp 1-7 (2019)
Abstract Background Lobular carcinoma in situ (LCIS) of the breast is a risk factor of developing invasive breast cancer. We evaluated the racial differences in the risks of subsequent invasive breast cancer following LCIS. Methods We utilized data f
Externí odkaz:
https://doaj.org/article/9c59dc88c0814eb89db24e8e0b8eecef
Autor:
Matthew J. Ellis, Souzan Sanati, Hussam Al-Kateb, Maria Koehler, Cynthia Huang Bartlett, Kiran Vij, Caroline Bumb, Shana Thomas, Malachi Griffith, Obi L. Griffith, Zachary L. Skidmore, Nicholas C. Spies, Michelle V. Lee, Zhanfang Guo, Helen Krontiras, Tina Hieken, Timothy J. Eberlein, Amy Cyr, William Gillanders, Timothy Moynihan, Timothy Hobday, Rebecca Aft, Julie Margenthaler, Karen S. Anderson, Rama Suresh, Foluso Ademuyiwa, Michael Naughton, Jeremy Hoog, Andres Forero, Matthew Goetz, Donald W. Northfelt, Jingqin Luo, Feng Gao, Cynthia X. Ma
Purpose: Cyclin-dependent kinase (CDK) 4/6 drives cell proliferation in estrogen receptor–positive (ER+) breast cancer. This single-arm phase II neoadjuvant trial (NeoPalAna) assessed the antiproliferative activity of the CDK4/6 inhibitor palbocicl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5405b1d4db6a955a56275a7511589430
https://doi.org/10.1158/1078-0432.c.6527120.v1
https://doi.org/10.1158/1078-0432.c.6527120.v1
Autor:
Matthew J. Ellis, Souzan Sanati, Hussam Al-Kateb, Maria Koehler, Cynthia Huang Bartlett, Kiran Vij, Caroline Bumb, Shana Thomas, Malachi Griffith, Obi L. Griffith, Zachary L. Skidmore, Nicholas C. Spies, Michelle V. Lee, Zhanfang Guo, Helen Krontiras, Tina Hieken, Timothy J. Eberlein, Amy Cyr, William Gillanders, Timothy Moynihan, Timothy Hobday, Rebecca Aft, Julie Margenthaler, Karen S. Anderson, Rama Suresh, Foluso Ademuyiwa, Michael Naughton, Jeremy Hoog, Andres Forero, Matthew Goetz, Donald W. Northfelt, Jingqin Luo, Feng Gao, Cynthia X. Ma
Supplementary Table S1 describes the AE profile, Supplementary S2 shows the results of clinical and radiologic responses.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cca1c1f8b032e5e78aa7b2f2ef837cc
https://doi.org/10.1158/1078-0432.22468994.v1
https://doi.org/10.1158/1078-0432.22468994.v1
Autor:
Matthew J. Ellis, Souzan Sanati, Hussam Al-Kateb, Maria Koehler, Cynthia Huang Bartlett, Kiran Vij, Caroline Bumb, Shana Thomas, Malachi Griffith, Obi L. Griffith, Zachary L. Skidmore, Nicholas C. Spies, Michelle V. Lee, Zhanfang Guo, Helen Krontiras, Tina Hieken, Timothy J. Eberlein, Amy Cyr, William Gillanders, Timothy Moynihan, Timothy Hobday, Rebecca Aft, Julie Margenthaler, Karen S. Anderson, Rama Suresh, Foluso Ademuyiwa, Michael Naughton, Jeremy Hoog, Andres Forero, Matthew Goetz, Donald W. Northfelt, Jingqin Luo, Feng Gao, Cynthia X. Ma
Supplementary Table S3 provides the result of the 83-gene panel next generation sequencing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::040ddc618e60063cfbe632e5978b5a92
https://doi.org/10.1158/1078-0432.22469018.v1
https://doi.org/10.1158/1078-0432.22469018.v1
Autor:
Matthew J. Ellis, Charles Erlichman, Laurence Doyle, Malachi Griffith, Obi L. Griffith, Hussam Al-Kateb, Souzan Sanati, Kiran Vij, Ian S. Hagemann, Elaine Mardis, Kari B. Wisinski, Leslie Nehring, Zhanfang Guo, Jeremy Hoog, Kilannin Krysiak, Yan-Yang Feng, Zachary L. Skidmore, Erica K. Barnell, Tina Hieken, Charles Loprinzi, Timothy Moynihan, Tufia Haddad, Lee Wilke, Amye Tevaarwerk, Richard Gray, Rebecca Aft, Julie Margenthaler, Michael Naughton, Foluso Ademuyiwa, Mark E. Burkard, Donald Northfelt, Matthew P. Goetz, Vera Suman, Cynthia X. Ma
Supplementary Figure Legends S1-S5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8264f8a52ff80ce649d98a844679d150
https://doi.org/10.1158/1078-0432.22463274.v1
https://doi.org/10.1158/1078-0432.22463274.v1
Autor:
Matthew J. Ellis, Craig Lockhart, Elaine Mardis, Jing Han, Jeremy Hoog, Zhanfang Guo, Shana Thomas, Gayathri Nagaraj, Timothy Pluard, Lee Trani, Avinash Ramu, Nicholas C. Spies, Zachary L. Skidmore, Obi L. Griffith, Malachi Griffith, Rama Suresh, Foluso Ademuyiwa, Michael Naughton, Jingqin Luo, Cynthia X. Ma
Supplementary Fig. S2. Mutations in selected genes observed in this trial in contrast to that in COSMIC data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::008137b9a94cccb34021fc5076d641dc
https://doi.org/10.1158/1078-0432.22458336.v1
https://doi.org/10.1158/1078-0432.22458336.v1
Autor:
Matthew J. Ellis, Charles Erlichman, Laurence Doyle, Malachi Griffith, Obi L. Griffith, Hussam Al-Kateb, Souzan Sanati, Kiran Vij, Ian S. Hagemann, Elaine Mardis, Kari B. Wisinski, Leslie Nehring, Zhanfang Guo, Jeremy Hoog, Kilannin Krysiak, Yan-Yang Feng, Zachary L. Skidmore, Erica K. Barnell, Tina Hieken, Charles Loprinzi, Timothy Moynihan, Tufia Haddad, Lee Wilke, Amye Tevaarwerk, Richard Gray, Rebecca Aft, Julie Margenthaler, Michael Naughton, Foluso Ademuyiwa, Mark E. Burkard, Donald Northfelt, Matthew P. Goetz, Vera Suman, Cynthia X. Ma
Purpose: Hyperactivation of AKT is common and associated with endocrine resistance in estrogen receptor–positive (ER+) breast cancer. The allosteric pan-AKT inhibitor MK-2206 induced apoptosis in PIK3CA-mutant ER+ breast cancer under estrogen-depri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::824ca18f79dabed32cbd89c9c0ffc7bd
https://doi.org/10.1158/1078-0432.c.6525357
https://doi.org/10.1158/1078-0432.c.6525357
Autor:
Matthew J. Ellis, Craig Lockhart, Elaine Mardis, Jing Han, Jeremy Hoog, Zhanfang Guo, Shana Thomas, Gayathri Nagaraj, Timothy Pluard, Lee Trani, Avinash Ramu, Nicholas C. Spies, Zachary L. Skidmore, Obi L. Griffith, Malachi Griffith, Rama Suresh, Foluso Ademuyiwa, Michael Naughton, Jingqin Luo, Cynthia X. Ma
Supplementary Table S3. All observed coding mutations with detailed annotations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63a5e2093cf00cebc7f95b5be81b1416
https://doi.org/10.1158/1078-0432.22458327
https://doi.org/10.1158/1078-0432.22458327
Autor:
Matthew J. Ellis, Craig Lockhart, Elaine Mardis, Jing Han, Jeremy Hoog, Zhanfang Guo, Shana Thomas, Gayathri Nagaraj, Timothy Pluard, Lee Trani, Avinash Ramu, Nicholas C. Spies, Zachary L. Skidmore, Obi L. Griffith, Malachi Griffith, Rama Suresh, Foluso Ademuyiwa, Michael Naughton, Jingqin Luo, Cynthia X. Ma
Purpose: This trial was conducted to determine the maximum tolerated dose (MTD) and preliminary efficacy of buparlisib, an oral pan-class I PI3K inhibitor, plus fulvestrant in postmenopausal women with metastatic estrogen receptor positive (ER+) brea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e05566e904a1cab873870852a1c7c3e
https://doi.org/10.1158/1078-0432.c.6523908
https://doi.org/10.1158/1078-0432.c.6523908